| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2c1255f214139ff3c830c810709d18e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-35 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b974144d691cfcd28f35879d5e2c5d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0804cd23a0cec007633193cc105d6594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c73603a84db91b71d4f29ec6df2324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f760c585ae7aaadf7a3d9dee26a16d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d599f5d76a6a9e42fbf4ccf55d60f05d |
| publicationDate |
2021-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2808673-T3 |
| titleOfInvention |
Immunogenic composition comprising mycoplasma antigens |
| abstract |
An immunogenic composition comprising: a) a complete inactivated bacterial M. hyorhinis vaccine and a complete inactivated bacterial M. hyosynoviae vaccine and a complete inactivated bacterial M.hyopneumoniae vaccine; and b) a pharmaceutically acceptable carrier. |
| priorityDate |
2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |